0001225208-20-004019.txt : 20200303
0001225208-20-004019.hdr.sgml : 20200303
20200303124907
ACCESSION NUMBER: 0001225208-20-004019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200228
FILED AS OF DATE: 20200303
DATE AS OF CHANGE: 20200303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CANGIALOSI LORETTA V
CENTRAL INDEX KEY: 0001174449
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 20680939
MAIL ADDRESS:
STREET 1: PFIZER INC. ATTN. CORPORATE SECRETARY
STREET 2: 235 EAST 42ND ST.
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0306
4
2020-02-28
1
0000078003
PFIZER INC
PFE
0001174449
CANGIALOSI LORETTA V
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK
NY
10017
1
Sr. Vice President, Controller
Common Stock
2020-02-28
4
M
0
27422.0000
27.3700
A
140744.0000
D
Common Stock
2020-02-28
4
F
0
4503.0000
33.4200
D
136241.0000
D
Common Stock
2020-02-28
4
F
0
14166.0000
36.4500
D
122075.0000
D
Common Stock
2686.0000
I
By Rule 16b-3 Plan
Stock Appreciation Rights
27.3700
2020-02-28
4
M
0
27422.0000
0.0000
D
2020-02-28
2020-02-28
Common Stock
27422.0000
0.0000
D
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Susan E. Grant, by power of atty., for Loretta V. Cangialosi
2020-03-03